These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 30830980)
1. Antifungal combinations in Mucorales: A microbiological perspective. Schwarz P; Cornely OA; Dannaoui E Mycoses; 2019 Sep; 62(9):746-760. PubMed ID: 30830980 [TBL] [Abstract][Full Text] [Related]
2. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. Riley TT; Muzny CA; Swiatlo E; Legendre DP Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416 [TBL] [Abstract][Full Text] [Related]
3. Antifungal resistance in mucorales. Dannaoui E Int J Antimicrob Agents; 2017 Nov; 50(5):617-621. PubMed ID: 28802855 [TBL] [Abstract][Full Text] [Related]
4. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment. Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357 [TBL] [Abstract][Full Text] [Related]
5. A mucormycosis case treated with a combination of caspofungin and amphotericin B. Kazak E; Aslan E; Akalın H; Saraydaroğlu O; Hakyemez B; Erişen L; Yazıcı B; Gürcüoğlu E; Yılmaz E; Ener B; Helvacı S J Mycol Med; 2013 Sep; 23(3):179-84. PubMed ID: 23856448 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis. Luo G; Gebremariam T; Lee H; French SW; Wiederhold NP; Patterson TF; Filler SG; Ibrahim AS Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163 [TBL] [Abstract][Full Text] [Related]
7. In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis. Thakur M; Revankar SG J Antimicrob Chemother; 2011 Oct; 66(10):2312-4. PubMed ID: 21795260 [TBL] [Abstract][Full Text] [Related]
8. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis. Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213 [TBL] [Abstract][Full Text] [Related]
9. Combination echinocandin-polyene treatment of murine mucormycosis. Ibrahim AS; Gebremariam T; Fu Y; Edwards JE; Spellberg B Antimicrob Agents Chemother; 2008 Apr; 52(4):1556-8. PubMed ID: 18212099 [TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms of Antifungal Resistance in Mucormycosis. Ganesan P; Ganapathy D; Sekaran S; Murthykumar K; Sundramoorthy AK; Pitchiah S; Shanmugam R Biomed Res Int; 2022; 2022():6722245. PubMed ID: 36277891 [TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of a persistent rhino-cerebral mucormycosis in a pediatric patient with a debut of acute lymphoblastic leukemia]. Cofré F; Villarroel M; Castellón L; Santolaya ME Rev Chilena Infectol; 2015 Aug; 32(4):458-63. PubMed ID: 26436794 [TBL] [Abstract][Full Text] [Related]
12. Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B. Voitl P; Scheibenpflug C; Weber T; Janata O; Rokitansky AM Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):632-4. PubMed ID: 12226700 [No Abstract] [Full Text] [Related]
13. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. Guinea J; Escribano P; Vena A; Muñoz P; Martínez-Jiménez MDC; Padilla B; Bouza E PLoS One; 2017; 12(6):e0179136. PubMed ID: 28591186 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Spellberg B; Fu Y; Edwards JE; Ibrahim AS Antimicrob Agents Chemother; 2005 Feb; 49(2):830-2. PubMed ID: 15673781 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model. Takemoto K; Yamamoto Y; Kanazawa K J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522 [TBL] [Abstract][Full Text] [Related]
16. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. Ibrahim AS; Gebermariam T; Fu Y; Lin L; Husseiny MI; French SW; Schwartz J; Skory CD; Edwards JE; Spellberg BJ J Clin Invest; 2007 Sep; 117(9):2649-57. PubMed ID: 17786247 [TBL] [Abstract][Full Text] [Related]